Skip to Main
Teon targets metabolic signaling pathways to restore antitumor immunity and suppress cancer cell proliferation
Teon targets metabolic signaling pathways to restore antitumor immunity and suppress cancer cell proliferation

Teon Therapeutics is developing a portfolio of single-target small molecules that affect metabolic signaling pathways in the tumor microenvironment. Our pipeline consists of first-in-class and best-in-class candidates with targets that affect both immune and cancer cells.